Lung Cancer Clinical Trial
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
Summary
Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.
Full Description
Screening for lung cancer has the potential for a profound public health benefit.
Successful population-based screening requires continuous monitoring to adherence repeat screening in high risk adults to achieve similar results. Repeat annual screening is necessary for early detection of lung cancer. Baseline or first LDCT scans detect prevalent lung cancer, when subsequent screening detects new nodules. However, adherence to screening is low, ranging at 28-38% from centers nationally.
The investigators developed two novel, patient-centered interventions to address patient education and offering reminders for on-time screening. To address these goals, the specific aims are to: 1) Compare effectiveness of two multilevel interventions relative to usual care in improving (a) rates of adherence to lung cancer screening, (b) patient-centered outcomes; and (c) clinic outcomes; and 2) Determine the patient-, clinician-, and system-level factors that influence changes in adherence to inform lung cancer screening programs.
Eligibility Criteria
Inclusion Criteria:
KPWA members
Aged 50-78 years
Have a negative screening LDCT scan
Speak English or Spanish
Meet US Preventive Services Task Force guidelines
Exclusion Criteria:
Patients who were previously diagnosed with lung cancer,
Patients who have a positive scan,
Patients who have an indicator for interpreter services, except for Spanish
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Seattle Washington, 98101, United States
How clear is this clinincal trial information?